Glycated hemoglobin News and Research

RSS

Study finds link between self-stigma and glycated hemoglobin in people with type 1 diabetes

Individuals with chronic medical conditions may experience self-stigma, or negative beliefs, emotional reactions, and behaviors towards themselves as a result of their illness.

25 Jan 2023

Study shows improved glucose control with fully closed-loop delivery of insulin in diabetics

Researchers investigated whether completely closed-loop insulin delivery could improve glycemic control among type 2 diabetes patients compared to regular insulin injections without any increase in hypoglycemia risks over 8.0 weeks of regular living.

13 Jan 2023

Review shows metformin usage to be associated with better COVID-19 outcomes

Researchers reported on the potential association between metformin usage and coronavirus disease 2019 (COVID-19) outcomes.

11 Jan 2023

Study suggests COVID-19 can cause diabetes

The authors of a new study under review at Nature Portfolio and currently posted to the Research Square preprint* server showed the clinical possibility that the coronavirus disease 2019 (COVID-19) heightens the risk of developing diabetes mellitus (DM), supporting diabetes screening in those infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Jan 2023

Keeping hydrated can reduce aging and extend disease-free life

In a recent study published in the journal eBioMedicine, researchers assessed the association between hydration and aging.

3 Jan 2023

How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

Researchers investigates the impact of the COVID-19 pandemic on pancreatic cancer services in England.

11 Dec 2022

Honey improves key measures of health, including blood sugar and cholesterol levels

Researchers look to better understand the impact of honey on mitigating certain cardiometabolic risk factors.

20 Nov 2022

Weekly weight loss drug reduces BMI in teens

Researchers report that a weekly dose of semaglutide led to a significant BMI reduction in adolescents.

3 Nov 2022

Bionic pancreas effective at maintaining blood glucose levels in people with type 1 diabetes

A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.

12 Oct 2022

Metformin reduces risk of severe COVID-19 in diabetic patients

A new study determines whether antidiabetic agents can reduce complications in COVID-19 patients with diabetes.

10 Oct 2022

Bionic pancreas more effective at maintaining blood glucose levels in people with type 1 diabetes

28 Sep 2022

Quinoa-based diet stabilizes blood sugar in older adults

A new study reports the ability of quinoa to normalize glucose metabolism in the body, particularly among the elderly with impaired glucose tolerance.

22 Sep 2022

Risk of dementia reduced 50% by walking 9,800 steps a day

In a recent study published in JAMA Neurology, researchers assessed the association between the number and intensity of steps taken per day and dementia incidence among adults residing in the United Kingdom (UK).

14 Sep 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

The risk of developing incident diabetes following hospital discharge or at least 28 days after COVID-19 diagnosis

Researchers evaluated the risk of developing incident diabetes mellitus post-acute phase of COVID-19.

7 Jun 2022

Study explores sex-driven differences in individualized clinical management of Alzheimer’s disease risk

A new study demonstrated how individualized clinical management of Alzheimer's disease risk was viable in a clinical outpatient setting.

29 Apr 2022

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Researchers examined the post-acute risk and burden of incident diabetes beyond the initial 30 days of COVID-19.

25 Mar 2022

Evidence of COVID-19 impacts on glycated hemoglobin levels in a real-world clinical cohort

Researchers established the impact of SARS-CoV-2 infection on glycated hemoglobin levels, type 2 diabetes risk, and diabetic ketoacidosis through data from the large real-world clinical cohort.

17 Mar 2022

COVID-19 vaccination humoral immune response in individuals with diabetes

A new study investigated the humoral immune response and side effects related to COVID-19 vaccines in individuals with type 1 diabetes and type 2 diabetes.

12 Nov 2021